Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Patients desire direct-to-consumer testing, but are the results this testing provides accurate and reliable?
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
The EasyScreen assay received 510(k) clearance from the Food and Drug Administration earlier this year–but with a catch
How artificial intelligence and machine learning tools stand to benefit clinical labs throughout the genomics pathway
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice